(AXSM) Axsome Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Axsome Therapeutics | (AXSM) share price targets
Complete technical analysis of Axsome Therapeutics (AXSM) by charts plus indicators, forecast predictions and share price targets for Axsome Therapeutics (AXSM)
Axsome Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-28 View latest technical analysis
10 day averaged volume of Axsome Therapeutics is 1009930
Date | Daily Closing Price | Open | High | Low | Volume |
28 Fri Feb 2025 | 127.54 | 126.41 | 128.77 | 126.03 | 0.843 times |
27 Thu Feb 2025 | 126.41 | 129.53 | 130.03 | 126.40 | 0.582 times |
26 Wed Feb 2025 | 128.33 | 128.09 | 130.95 | 126.43 | 0.779 times |
25 Tue Feb 2025 | 127.09 | 130.88 | 131.99 | 124.07 | 1.22 times |
24 Mon Feb 2025 | 130.72 | 137.76 | 137.76 | 129.23 | 1.143 times |
21 Fri Feb 2025 | 137.75 | 130.04 | 139.13 | 128.39 | 1.524 times |
20 Thu Feb 2025 | 129.10 | 128.13 | 129.41 | 125.88 | 0.7 times |
19 Wed Feb 2025 | 126.96 | 128.81 | 130.52 | 124.52 | 0.863 times |
18 Tue Feb 2025 | 128.09 | 124.66 | 130.15 | 124.04 | 1.548 times |
14 Fri Feb 2025 | 131.15 | 131.61 | 132.12 | 129.35 | 1.054 times |
My analysis of stock is bullish for shortterm, and stock might move up till 133.4 or till 145.1. Use a stoploss of 123.59 and if this stock hits its stoploss, then it can fall down till 113.79
Share price targets for Axsome Therapeutics (AXSM)
Target Type | Value |
Downside Target | 75.56 |
Downside Target | 79.19 |
Downside Target | 80.85 |
Downside Target | 86.06 |
Downside Target | 95.72 |
Downside Target | 100.93 |
Downside Target | 111.51 |
Downside Target | 114.06 |
Downside Target | 116.81 |
Downside Target | 124.04 |
Downside Target | 124.07 |
Upside Target | 134.19 |
Upside Target | 137.76 |
Upside Target | 139.13 |
Intraday share price targets for Axsome Therapeutics (AXSM)
Target Type | Value |
Downside Intraday Target | 121.82 |
Downside Intraday Target | 116.1 |
Upside Intraday Target | 135.51 |
Upside Intraday Target | 143.48 |
Upside Intraday Target | 129.79 |
Weekly technical analysis of Axsome Therapeutics (AXSM)
Date | Weekly Closing Price | Open | High | Low | Volume |
28 Fri Feb 2025 | 127.54 | 137.76 | 137.76 | 124.07 | 0.985 times |
21 Fri Feb 2025 | 137.75 | 124.66 | 139.13 | 124.04 | 0.531 times |
14 Fri Feb 2025 | 131.15 | 123.44 | 134.19 | 116.81 | 2.077 times |
07 Fri Feb 2025 | 105.76 | 106.00 | 114.06 | 103.98 | 0.936 times |
31 Fri Jan 2025 | 106.46 | 102.94 | 111.51 | 100.93 | 1.08 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Axsome Therapeutics (AXSM)
Date | Monthly Closing Price | Open | High | Low | Volume |
28 Fri Feb 2025 | 127.54 | 106.00 | 139.13 | 103.98 | 1.066 times |
31 Fri Jan 2025 | 106.46 | 85.25 | 111.51 | 79.19 | 1.805 times |
31 Tue Dec 2024 | 84.62 | 100.21 | 102.30 | 75.56 | 0.977 times |
26 Tue Nov 2024 | 97.03 | 89.06 | 105.00 | 86.06 | 1.257 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Axsome Therapeutics (AXSM)
Price action analysis of Axsome Therapeutics ( (AXSM) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Axsome Therapeutics ( (AXSM) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Axsome Therapeutics ( (AXSM) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Axsome Therapeutics ( (AXSM) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Axsome Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Axsome Therapeutics in short term but the sell signal is initial and weak.
Axsome Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Axsome Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Axsome Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 129.87 and Axsome Therapeutics (AXSM) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Axsome Therapeutics (AXSM) stock. Volume based technical analysis of Axsome Therapeutics (AXSM) stock is negative.
Axsome Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Axsome Therapeutics ( (AXSM) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Axsome Therapeutics ( (AXSM) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Axsome Therapeutics ( (AXSM) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Axsome Therapeutics ( (AXSM) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Axsome Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Axsome Therapeutics in short term but the sell signal is initial and weak.
Axsome Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Axsome Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Axsome Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 129.87 and Axsome Therapeutics (AXSM) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Axsome Therapeutics (AXSM) stock. Volume based technical analysis of Axsome Therapeutics (AXSM) stock is negative.
Axsome Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.